Colorectal Cancer Drugs Market 2025

Name: Colorectal Cancer Drugs Market 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Download Sample Buy Report

Colorectal Cancer Drugs Global Market Opportunities And Strategies To 2034

Colorectal Cancer Drugs Market 2025 - By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Other Cancer Types), By Class (Targeted Therapy, Immunotherapy, Chemotherapy, Other Classes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), And By Region, Opportunities And Strategies – Global Forecast To 2035

Colorectal Cancer Drugs Market 2025

Report Price : $4490.00 | Pages : 337 | Published : November 2025 | Delivery Time: Immediately | Format :

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Regional Data

Colorectal Cancer Drugs Market Definition

Colorectal cancer drugs refer to pharmaceutical treatments developed to prevent, manage, or cure cancer that begins in the colon or rectum. These drugs include various therapeutic approaches designed to target cancer cells, slow disease progression and improve survival rates. They play a crucial role in reducing the global burden of colorectal cancer by enhancing patient outcomes.

The colorectal cancer drugs market consists of the sales of colorectal cancer drugs by entities (organizations, sole traders, or partnerships) that develop, manufacture and distribute pharmaceutical products aimed at treating cancers of the colon and rectum. These drugs are designed to improve survival, reduce disease progression and enhance the quality of life for patients. The market reflects advancements in oncology research, growing healthcare investments and rising global demand for effective cancer therapies.

Colorectal Cancer Drugs Global Market Opportunities And Strategies To 2034 Market Size and growth rate 2025 to 2029: Graph

Colorectal Cancer Drugs Market Size

The global colorectal cancer drugs market reached a value of nearly $12,951.67 million in 2024, having grown at a compound annual growth rate (CAGR) of 6.74% since 2019. The market is expected to grow from $12,951.67 million in 2024 to $16,885.59 million in 2029 at a rate of 5.45%. The market is then expected to grow at a CAGR of 5.37% from 2029 and reach $21,935.16 million in 2034.

Growth in the historic period resulted from rising clinical trial activity in pharma, rising incidence of colorectal cancer, favorable government initiatives and funding and growth of precision medicine and targeted therapies. Factors that negatively affected growth in the historic period were high treatment costs and affordability issues and severe side effects and toxicities of chemotherapy and biologics.

Going forward, increasing awareness and screening programs, increasing healthcare expenditure, growing use of combination therapies and rise in aging population will drive growth. Factors that could hinder the growth of the colorectal cancer drugs market in the future include reimbursement challenges for novel drugs, stringent regulatory approval processes and impact of trade war and tariff.

Colorectal Cancer Drugs Market Drivers

The key drivers of the colorectal cancer drugs market include:

Rise In Aging Population

The growing aging population is expected to significantly drive the growth of the colorectal cancer drugs market during the forecast period. Older individuals face a higher risk of developing colorectal cancer due to factors such as age-related genetic mutations, long-term lifestyle influences and a decline in immune function. As the global population aged 60 and above continues to expand, the incidence of colorectal cancer is projected to rise accordingly, fueling increased demand for effective treatment options. This demographic trend also highlights the need for treatment approaches specifically designed for elderly patients, who often have comorbidities and greater sensitivity to drug toxicity. In response, healthcare systems are placing greater emphasis on geriatric oncology, enhanced screening efforts and preventive measures to address the growing cancer burden among older adults. As a result, the rising elderly population is expected to be a key driver of market demand for colorectal cancer drugs throughout the forecast period. The rise in aging population contribution during the forecast period in 2024 is 2.00%.

Colorectal Cancer Drugs Market Restraints

The key restraints on the colorectal cancer drugs market include:

Stringent Regulatory Approval Processes

Stringent regulatory approval processes are expected to hinder the growth of the colorectal cancer drugs market during the forecast period. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce comprehensive and rigorous standards for clinical trials, safety assessments and efficacy validation. While these regulations are essential for ensuring patient safety, they can significantly delay the approval and launch of new therapies. The growing emphasis on complex biologics and targeted molecular treatments further intensifies the regulatory burden, as these drugs require extensive testing, longer trial durations and more detailed documentation. As a result, pharmaceutical companies face higher development costs and prolonged time-to-market, which can reduce the pace of innovation and limit patient access to new therapies. These regulatory hurdles, while necessary for quality assurance, remain a critical barrier to the timely expansion and accessibility of advanced colorectal cancer treatments. Growth affected by stringent regulatory approval processes during the forecast period in 2024 is -2.14%.

Colorectal Cancer Drugs Market Trends

Major trends shaping the colorectal cancer drugs market include:

Biosimilar Innovations Enhancing Accessibility And Reducing Costs In Colorectal Cancer

Companies operating in the colorectal cancer drugs market are developing biosimilars to expand treatment accessibility, lower overall therapy costs and provide affordable alternatives to high-priced biologics, while maintaining equivalent safety, efficacy and quality to the reference drugs. Biosimilars also aim to increase patient adherence by reducing financial barriers and to enable broader adoption of standard-of-care therapies in regions with constrained healthcare budgets. For example, in April 2025, Biocon Biologics, an India-based biopharmaceutical company, received approval from the Food and Drug Administration, a US-based federal agency, for Jobevne, a bevacizumab biosimilar indicated for the treatment of metastatic colorectal cancer and other cancers. Jobevne is a biosimilar to Avastin and demonstrates comparable safety, efficacy and quality, while providing a lower-cost alternative that can improve patient access and affordability. It can be used in combination with chemotherapy regimens for metastatic colorectal cancer, supporting broader adoption of standard-of-care therapies, particularly in markets with constrained healthcare budgets.

Advancing Frontline Treatment In BRAF V600E-Mutant Metastatic Colorectal Cancer

Major companies in the colorectal cancer drugs market are moving targeted therapies into frontline treatment settings by combining BRAF (v-Raf murine sarcoma viral oncogene homolog B1) inhibitors with EGFR (Epidermal Growth Factor Receptor) blockade and chemotherapy for patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC). This shift is driven by the recognition that patients with BRAF V600E mutations typically have poor prognoses and limited response to standard chemotherapy alone. For example, in December 2024, Pfizer, a US-based biopharmaceutical company, received approval from the Food and Drug Administration, a US-based federal agency, for BRAFTOVI in combination with cetuximab as a first-line treatment for adult patients with BRAF V600E-mutant metastatic colorectal cancer. This approval marks a significant advancement in targeted therapy, providing a personalized treatment option that specifically addresses the BRAF V600E mutation, which is associated with aggressive disease and poor prognosis. The combination regimen is expected to improve clinical outcomes and expand first-line therapy options for patients with this molecular subtype of colorectal cancer.

Opportunities And Recommendations In The colorectal cancer drugs Market

Opportunities – The top opportunities in the colorectal cancer drugs market segmented by cancer type will arise in the colorectal adenocarcinoma segment, which will gain $3,571.68 million of global annual sales by 2029. The top opportunities in the colorectal cancer drugs market segmented by class will arise in the targeted therapy segment, which will gain $1,438.85 million of global annual sales by 2029. The top opportunities in the colorectal cancer drugs market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $1,763.03 million of global annual sales by 2029. The colorectal cancer drugs market size will gain the most in the USA at $1,437.78 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the colorectal cancer drug companies to focus on expanding biosimilar portfolios to enhance access and affordability, focus on advancing targeted therapies into first-line treatment for improved outcomes, focus on expanding combination regimens targeting kras g12c-mutant colorectal cancer, focus on advancing next-generation oral tkis to improve late-line treatment options, focus on the gastrointestinal carcinoid tumors segment for accelerated growth, focus on the immunotherapy segment to drive long-term market expansion, expand in emerging markets, focus on strengthening multi-channel distribution networks, focus on developing value-based and region-specific pricing strategies, focus on strengthening evidence-based engagement with healthcare stakeholders, focus on expanding digital and data-driven promotional channels, focus on the retail pharmacies segment to capture emerging growth opportunities.

Book your 30 minutes free consultation with our research experts

Colorectal Cancer Drugs Market Segmentation

The colorectal cancer drugs market is segmented by cancer type, by class, and by distribution channels.

By Cancer Type –

The colorectal cancer drugs market is segmented by cancer type into:

a) Colorectal Adenocarcinoma

b) Gastrointestinal Carcinoid Tumors

c) Other Cancer Types

The colorectal adenocarcinoma market was the largest segment of the colorectal cancer drugs market segmented by cancer type, accounting for 92.48% or $11,977.79 million of the total in 2024. Going forward, the gastrointestinal carcinoid tumors segment is expected to be the fastest growing segment in the colorectal cancer drugs market segmented by cancer type, at a CAGR of 10.29% during 2024-2029.

By Class –

The colorectal cancer drugs market is segmented by class into:

a) Targeted Therapy

b) Immunotherapy

c) Chemotherapy

d) Other Classes

The chemotherapy market was the largest segment of the colorectal cancer drugs market segmented by class, accounting for 45.60% or $5,905.53 million of the total in 2024. Going forward, the immunotherapy segment is expected to be the fastest growing segment in the colorectal cancer drugs market segmented by class, at a CAGR of 8.10% during 2024-2029.

By Distribution Channels –

The colorectal cancer drugs market is segmented by distribution channels into:

a) Hospital Pharmacies

b) Hospital Pharmacies

c) Other Distribution Channels

The hospital pharmacies market was the largest segment of the colorectal cancer drugs market segmented by distribution channel, accounting for 50.27% or $6,511.09 million of the total in 2024. Going forward, the retail pharmacies segment is expected to be the fastest growing segment in the colorectal cancer drugs market segmented by distribution channel, at a CAGR of 6.29% during 2024-2029.

By Geography - The colorectal cancer drugs market is segmented by geography into:

o Asia Pacific

• China

• India

• Japan

• Australia

• Indonesia

• South Korea

o North America

• USA

• Canada

o South America

• Brazil

o Western Europe

• France

• Germany

• UK

• Italy

• Spain

o Eastern Europe

• Russia

o Middle East

o Africa

North America was the largest region in the colorectal cancer drugs market, accounting for 43.68% or $5,657.74 million of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the colorectal cancer drugs market will be Asia Pacific and Middle East where growth will be at CAGRs of 6.75% and 6.34% respectively. These will be followed by Africa and Eastern Europe where the markets are expected to grow at CAGRs of 6.25% and 5.10% respectively.

Colorectal Cancer Drugs Market Competitive Landscape

Major Competitors are:

Merck & Co. Inc.

Amgen Inc.

Bristol-Myers Squibb

F. Hoffmann-La Roche Ltd.

Eli Lilly & Company

Other Competitors Include:

Bayer AG

Takeda Pharmaceutical Company

Pfizer Inc.

Sanofi

Taiho Pharmaceutical

Simcere Zaiming Pharmaceutical Co. Ltd.

Jiangsu Hengrui Pharmaceuticals Company Ltd.

Innovent Biologics

Junshi Biosciences

Shanghai Pharmaceuticals

CSPC Pharmaceutical Group

Hutchmed

Zai Lab

WuXi AppTec

Fosun Pharma

Chugai Pharmaceutical Co. Ltd.

Daiichi Sankyo Company Limited

Celltrion Inc.

Samsung Biologics

Novartis AG

AstraZeneca plc

Evonik Industries AG

Genentech

Fusion Pharmaceuticals

NEXT Oncology

Hikma Pharmaceuticals

Astellas Pharma Inc.

Servier Laboratories

Alkem Laboratories

Zydus Group

Gilead Sciences

Author: Abdul Wasay

1 Executive Summary

1.1 Colorectal Cancer Drugs – Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition

6.2 Summary

6.3 Colorectal Cancer Drugs Market Definition And Segmentations

6.4 Market Segmentation By Cancer Type

6.4.1 Colorectal Adenocarcinoma

6.4.2 Gastrointestinal Carcinoid Tumors

6.4.3 Other Cancer Types

6.5 Market Segmentation By Class

6.5.1 Targeted Therapy

6.5.2 Immunotherapy

6.5.3 Chemotherapy

6.5.4 Other Classes

6.6 Market Segmentation By Distribution Channels

6.6.1 Hospital Pharmacies

6.6.2 Retail Pharmacies

6.6.3 Other Distribution Channels

7 Major Market Trends

7.1 Biosimilar Innovations Enhancing Accessibility And Reducing Costs In Colorectal Cancer

7.2 Advancing Frontline Treatment In BRAF V600E-Mutant Metastatic Colorectal Cancer

7.3 Combination Of EGFR Inhibitors With KRAS G12C-Targeted Agents To Overcome Resistance In Advanced Colorectal Cancer

7.4 Next-Generation Tyrosine Kinase Inhibitors Expanding Treatment Options In Metastatic Colorectal Cancer

8 Global Colorectal Cancer Drugs Growth Analysis And Strategic Analysis Framework

8.1 Global: PESTEL Analysis

8.1.1 Political

8.1.2 Economic

8.1.3 Social

8.1.4 Technological

8.1.5 Environmental

8.1.6 Legal

8.2 Analysis of End Users (B2B)

8.2.1 Hospitals

8.2.2 Specialty Clinics

8.2.3 Cancer Treatment and Research Centers

8.2.4 Homecare Settings

8.2.5 Ambulatory Surgical Centers

8.3 Global Colorectal Cancer Drugs Market Growth Rate Analysis

8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)

8.4.1 Market Drivers 2019 – 2024

8.4.2 Market Restraints 2019 – 2024

8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

8.6 Forecast Growth Contributors/Factors

8.6.1 Quantitative Growth Contributors

8.6.2 Drivers

8.6.3 Restraints

8.7 Global Colorectal Cancer Drugs Total Addressable Market (TAM)

9 Global Colorectal Cancer Drugs Market Segmentation

9.1 Global Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.2 Global Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.3 Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.4 Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Localized Or Resectable Adenocarcinoma (Stages 0–III), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.5 Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Gastrointestinal Carcinoid Tumors, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

9.6 Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

10 Colorectal Cancer Drugs Market, Regional and Country Analysis

10.1 Global Colorectal Cancer Drugs Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

10.2 Global Colorectal Cancer Drugs Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

11.1 Summary

11.2 Market Overview

11.2.1 Region Information

11.2.2 Market Information

11.2.3 Background Information

11.2.4 Government Initiatives

11.2.5 Regulations

11.2.6 Regulatory Bodies

11.2.7 Major Associations

11.2.8 Taxes Levied

11.2.9 Corporate Tax Structure

11.2.10 Investments

11.2.11 Major Companies

11.3 Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.4 Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.5 Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.6 China Market

11.7 Summary

11.8 Market Overview

11.8.1 Country Information

11.8.2 Market Information

11.8.3 Background Information

11.8.4 Government Initiatives

11.8.5 Regulations

11.8.6 Regulatory Bodies

11.8.7 Major Associations

11.8.8 Taxes Levied

11.8.9 Corporate Tax Structure

11.8.10 Investments

11.8.11 Major Companies

11.9 China Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.10 China Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.11 China Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.12 India Market

11.13 India Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.14 India Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.15 India Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.16 Japan Market

11.17 Summary

11.18 Market Overview

11.18.1 Country Information

11.18.2 Market Information

11.18.3 Background Information

11.18.4 Government Initiatives

11.18.5 Regulations

11.18.6 Regulatory Bodies

11.18.7 Major Associations

11.18.8 Taxes Levied

11.18.9 Corporate Tax Structure

11.18.10 Investments

11.18.11 Major Companies

11.19 Japan Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.20 Japan Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.21 Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.22 South Korea Market

11.23 Summary

11.24 Market Overview

11.24.1 Country Information

11.24.2 Market Information

11.24.3 Background Information

11.24.4 Government Initiatives

11.24.5 Regulations

11.24.6 Regulatory Bodies

11.24.7 Major Associations

11.24.8 Taxes Levied

11.24.9 Corporate Tax Structure

11.24.10 Investments

11.24.11 Major Companies

11.25 South Korea Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.26 South Korea Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.27 South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.28 Australia Market

11.29 Australia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.30 Australia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.31 Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.32 Indonesia Market

11.33 Indonesia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.34 Indonesia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

11.35 Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

12.1 Summary

12.2 Market Overview

12.2.1 Region Information

12.2.2 Market Information

12.2.3 Background Information

12.2.4 Government Initiatives

12.2.5 Regulations

12.2.6 Regulatory Bodies

12.2.7 Major Associations

12.2.8 Taxes Levied

12.2.9 Corporate tax structure

12.2.10 Investments

12.2.11 Major Companies

12.3 Western Europe Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.4 Western Europe Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.5 Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.6 Western Europe Colorectal Cancer Drugs Market: Country Analysis

12.7 UK Market

12.8 UK Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.9 UK Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.10 UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.11 Germany Market

12.12 Germany Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.13 Germany Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.14 Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.15 France Market

12.16 France Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.17 France Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.18 France Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.19 Italy Market

12.20 Italy Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.21 Italy Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.22 Italy Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.23 Spain Market

12.24 Spain Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.25 Spain Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

12.26 Spain Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

13.1 Summary

13.2 Market Overview

13.2.1 Region Information

13.2.2 Market Information

13.2.3 Background Information

13.2.4 Government Initiatives

13.2.5 Regulations

13.2.6 Regulatory Bodies

13.2.7 Major Associations

13.2.8 Taxes Levied

13.2.9 Corporate Tax Structure

13.2.10 Investments

13.2.11 Major companies

13.3 Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.4 Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.5 Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.6 Eastern Europe Colorectal Cancer Drugs Market: Country Analysis

13.7 Russia Market

13.8 Russia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.9 Russia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

13.10 Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

14.1 Summary

14.2 Market Overview

14.2.1 Region Information

14.2.2 Market Information

14.2.3 Background Information

14.2.4 Government Initiatives

14.2.5 Regulations

14.2.6 Regulatory Bodies

14.2.7 Major Associations

14.2.8 Taxes Levied

14.2.9 Corporate Tax Structure

14.2.10 Investments

14.2.11 Major Companies

14.3 North America Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.4 North America Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.5 North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.6 North America Colorectal Cancer Drugs Market: Country Analysis

14.7 USA Market

14.8 Summary

14.9 Market Overview

14.9.1 Country Information

14.9.2 Market Information

14.9.3 Background Information

14.9.4 Government Initiatives

14.9.5 Regulations

14.9.6 Regulatory Bodies

14.9.7 Major Associations

14.9.8 Taxes Levied

14.9.9 Corporate Tax Structure

14.9.10 Investments

14.9.11 Major Companies

14.10 USA Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.11 USA Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.12 USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.13 Canada Market

14.14 Summary

14.15 Market Overview

14.15.1 Country Information

14.15.2 Market Information

14.15.3 Background Information

14.15.4 Government Initiatives

14.15.5 Regulations

14.15.6 Regulatory Bodies

14.15.7 Major Associations

14.15.8 Taxes Levied

14.15.9 Corporate Tax Structure

14.15.10 Investments

14.15.11 Major Companies

14.16 Canada Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.17 Canada Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

14.18 Canada Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

15.1 Summary

15.2 Market Overview

15.2.1 Region Information

15.2.2 Market Information

15.2.3 Background Information

15.2.4 Government Initiatives

15.2.5 Regulations

15.2.6 Regulatory Bodies

15.2.7 Major Associations

15.2.8 Taxes Levied

15.2.9 Corporate Tax Structure

15.2.10 Investments

15.2.11 Major Companies

15.3 South America Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.4 South America Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.5 South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.6 Brazil Market

15.7 Brazil Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.8 Brazil Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

15.9 Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

16.1 Summary

16.2 Market Overview

16.2.1 Region Information

16.2.2 Market Information

16.2.3 Background Information

16.2.4 Government Initiatives

16.2.5 Regulations

16.2.6 Regulatory Bodies

16.2.7 Major Associations

16.2.8 Taxes Levied

16.2.9 Corporate Tax Structure

16.2.10 Investments

16.2.11 Major Companies

16.3 Middle East Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16.4 Middle East Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

16.5 Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

17.1 Summary

17.2 Market Overview

17.2.1 Region Information

17.2.2 Market Information

17.2.3 Background Information

17.2.4 Government Initiatives

17.2.5 Regulations

17.2.6 Regulatory Bodies

17.2.7 Major Associations

17.2.8 Taxes Levied

17.2.9 Corporate Tax Structure

17.2.10 Investments

17.2.11 Major Companies

17.3 Africa Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17.4 Africa Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

17.5 Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

18.1 Company Profiles

18.2 Merck & Co., Inc

18.2.1 Company Overview

18.2.2 Products And Services

18.2.3 Business Strategy

18.2.4 Financial Overview

18.3 Amgen Inc

18.3.1 Company Overview

18.3.2 Products And Services

18.3.3 Business Strategy

18.3.4 Financial Overview

18.4 Bristol Myers Squibb Company

18.4.1 Company Overview

18.4.2 Products And Services

18.4.3 Business Strategy

18.4.4 Financial Overview

18.5 F. Hoffman-La Roche Ltd

18.5.1 Company Overview

18.5.2 Products And Services

18.5.3 Business Strategy

18.5.4 Financial Overview

18.6 Eli Lilly and Company

18.6.1 Company Overview

18.6.2 Products And Services

18.6.3 Financial Overview

19 Other Major And Innovative Companies

19.1 Bayer AG

19.1.1 Company Overview

19.1.2 Products And Services

19.2 Takeda Pharmaceutical Company

19.2.1 Company Overview

19.2.2 Products And Services

19.3 Pfizer Inc.

19.3.1 Company Overview

19.3.2 Products And Services

19.4 Sanofi

19.4.1 Company Overview

19.4.2 Products And Services

19.5 Taiho Pharmaceutical

19.5.1 Company Overview

19.5.2 Products And Services

19.6 Johnson & Johnson

19.6.1 Company Overview

19.6.2 Products And Services

19.7 Exelixis

19.7.1 Company Overview

19.7.2 Products And Services

19.8 AstraZeneca

19.8.1 Company Overview

19.8.2 Products And Services

19.9 Daiichi Sankyo Company Limited

19.9.1 Company Overview

19.9.2 Products And Services

19.10 AkesoBio

19.10.1 Company Overview

19.10.2 Products And Services

19.11 Arcuc Bioscience

19.11.1 Company Overview

19.11.2 Products And Services

19.12 Cardiff Oncology

19.12.1 Company Overview

19.12.2 Products And Services

19.13 Shanghai Henlius Biotech

19.13.1 Company Overview

19.13.2 Products And Services

19.14 Merus

19.14.1 Company Overview

19.14.2 Products And Services

19.15 Sumitomo Pharma

19.15.1 Company Overview

19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

22.1 Sun Pharmaceutical Industries Ltd. Acquired Checkpoint Therapeutics

22.2 Bristol-Myers Squibb Acquired Mirati Therapeutics

23 Recent Developments In The Colorectal Cancer Drugs Market

23.1 Affordable Generic And Value-Based Pricing Initiatives To Lower Patient Access Barriers

23.2 Bristol Myers Squibb Expands Colorectal Cancer Treatment With FDA-Approved Immunotherapy

23.3 Targeted Combination Therapy For KRAS G12C Colorectal Cancer Gains FDA Clearance

24 Opportunities And Strategies

24.1 Global Colorectal Cancer Drugs Market In 2029 – Countries Offering Most New Opportunities

24.2 Global Colorectal Cancer Drugs Market In 2029 – Segments Offering Most New Opportunities

24.3 Global Colorectal Cancer Drugs Market In 2029 – Growth Strategies

24.3.1 Market Trend Based Strategies

24.3.2 Competitor Strategies

25 Colorectal Cancer Drugs Market, Conclusions And Recommendations

25.1 Conclusions

25.2 Recommendations

25.2.1 Product

25.2.2 Place

25.2.3 Price

25.2.4 Promotion

25.2.5 People

26 Appendix

26.1 Geographies Covered

26.2 Market Data Sources

26.3 Research Methodology

26.4 Currencies

26.5 The Business Research Company

26.6 Copyright and Disclaimer

List Of Tables

Table 1: Global Colorectal Cancer Drugs Market, Historic, 2019 – 2024, $ Million

Table 2: Global Colorectal Cancer Drugs Market, Forecast, 2024 – 2029, 2034F, $ Million

Table 3: Global Colorectal Cancer Drugs Market TAM, 2024 And 2034, $ Million

Table 4: Global Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 5: Global Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 6: Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 7: Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Localized Or Resectable Adenocarcinoma (Stages 0–III), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 8: Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Gastrointestinal Carcinoid Tumors, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 9: Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 10: Global Colorectal Cancer Drugs Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 11: Global Colorectal Cancer Drugs Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 12: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $

Table 13: Asia-Pacific Population, By Country, 2019-2029, Millions

Table 14: Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 15: Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 16: Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 17: China GDP Per Capita, 2019-2024, $

Table 18: China Population, 2019-2029, Millions

Table 19: China Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 20: China Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 21: China Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 22: India Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 23: India Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 24: India Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 25: Japan GDP Per Capita, 2019-2024, $

Table 26: Japan Population, By Country, 2019-2029, Millions

Table 27: Japan Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 28: Japan Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 29: Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 30: South Korea GDP Per Capita, 2019-2024, $

Table 31: South Korea Population, 2019-2029, Millions

Table 32: South Korea Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 33: South Korea Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 34: South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 35: Australia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 36: Australia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 37: Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 38: Indonesia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 39: Indonesia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 40: Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 41: Western Europe GDP Per Capita, By Country, 2019-2024, $

Table 42: Western Europe Population, By Country, 2019-2029, Millions

Table 43: Western Europe Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 44: Western Europe Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 45: Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 46: UK Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 47: UK Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 48: UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 49: Germany Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 50: Germany Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 51: Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 52: France Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 53: France Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 54: France Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 55: Italy Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 56: Italy Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 57: Italy Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 58: Spain Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 59: Spain Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 60: Spain Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 61: Eastern Europe GDP Per Capita, By Country, 2019-2024, $

Table 62: Eastern Europe Population, By Country, 2019-2029, Millions

Table 63: Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 64: Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 65: Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 66: Russia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 67: Russia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 68: Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 69: North America GDP Per Capita, By Country, 2019-2024, $

Table 70: North America Population, By Country, 2019-2029, Millions

Table 71: North America Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 72: North America Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 73: North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 74: USA GDP Per Capita, 2019-2024, $

Table 75: USA Population, 2019-2029, Millions

Table 76: USA Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 77: USA Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 78: USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 79: Canada GDP Per Capita, 2019-2024, $

Table 80: Canada Population, By Country, 2019-2029, Millions

Table 81: Canada Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 82: Canada Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 83: Canada Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 84: South America GDP Per Capita, By Country, 2019-2024, $

Table 85: South America Population, By Country, 2019-2029, Millions

Table 86: South America Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 87: South America Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 88: South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 89: Brazil Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 90: Brazil Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 91: Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 92: Middle East GDP Per Capita, By Country, 2019-2024, $

Table 93: Middle East Population, By Country, 2019-2029, Millions

Table 94: Middle East Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 95: Middle East Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 96: Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 97: Africa GDP Per Capita, By Country, 2019-2024, $

Table 98: Africa Population, By Country, 2019-2029, Millions

Table 99: Africa Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 100: Africa Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 101: Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Table 102: Global Colorectal Cancer Drugs Market, Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 103: Merck & Co., Inc – Financial Overview, 2020 – 2024, $Billion

Table 104: Amgen Inc – Financial Overview, 2020 – 2024, $Billion

Table 105: Bristol-Myers Squibb Company – Financial Overview, 2020 – 2024, $ Billion

Table 106: F. Hoffmann-La Roche Ltd – Financial Overview, 2020 – 2024, $Billion

Table 107: Colorectal Cancer Drugs Market, Competitive Benchmarking (In USD Million)

Table 108: Biologics Market, Competitive Dashboard

Table 109: Global Colorectal Cancer Drugs Market Size Gain ($ Million), 2024 – 2029, By Country

Table 110: Global Colorectal Cancer Drugs Market Size Gain ($ Million), Segmentation By Cancer Type, 2024 – 2029

Table 111: Global Colorectal Cancer Drugs Market Size Gain ($ Million), Segmentation By Class, 2024 – 2029

Table 112: Global Colorectal Cancer Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2024 – 2029

Table 113: Colorectal Cancer Drugs Market Data Sources

List Of Figures

Figure 1: Global Colorectal Cancer Drugs Market Segmentation By Cancer Type

Figure 2: Global Colorectal Cancer Drugs Market Segmentation By Class

Figure 3: Global Colorectal Cancer Drugs Market Segmentation By Distribution Channels

Figure 4: Global Colorectal Cancer Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 5: Global Colorectal Cancer Drugs Market, Historic, 2019 – 2024, $ Million

Figure 6: Global Colorectal Cancer Drugs Market, Forecast, 2024 – 2029, 2034F, $ Million

Figure 7: Global Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 8: Global Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 9: Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 10: Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Localized Or Resectable Adenocarcinoma (Stages 0–III), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 11: Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Gastrointestinal Carcinoid Tumors, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 12: Global Colorectal Cancer Drugs Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 13: Global Colorectal Cancer Drugs Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 14: Global Colorectal Cancer Drugs Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 15: Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 16: Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 17: Asia Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 18: China Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 19: China Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 20: China Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 21: India Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 22: India Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 23: India Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 24: Japan Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 25: Japan Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 26: Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 27: South Korea Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 28: South Korea Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 29: South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 30: Australia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 31: Australia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 32: Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 33: Indonesia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 34: Indonesia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 35: Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 36: Western Europe Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 37: Western Europe Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 38: Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 39: UK Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 40: UK Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 41: UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 42: Germany Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 43: Germany Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 44: Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 45: France Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 46: France Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 47: France Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 48: Italy Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 49: Italy Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 50: Italy Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 51: Spain Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 52: Spain Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 53: Spain Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 54: Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 55: Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 56: Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 57: Russia Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 58: Russia Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 59: Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 60: North America Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 61: North America Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 62: North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 63: USA Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 64: USA Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 65: USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 66: Canada Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 67: Canada Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 68: Canada Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 69: South America Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 70: South America Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 71: South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 72: Brazil Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 73: Brazil Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 74: Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 75: Middle East Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 76: Middle East Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 77: Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 78: Africa Colorectal Cancer Drugs Market, Segmentation By Cancer Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 79: Africa Colorectal Cancer Drugs Market, Segmentation By Class, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 80: Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million

Figure 81: Global Colorectal Cancer Drugs, Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 82: Merck & Co., Inc – Financial Overview, 2020 – 2024, $ Billion

Figure 83: Amgen Inc – Financial Overview, 2020 – 2024, $ Billion

Figure 84: Bristol-Myers Squibb Company – Financial Overview, 2020 – 2024, $ Billion

Figure 85: F. Hoffmann-La Roche Ltd – Financial Overview, 2020 – 2024, $ Billion

Figure 86: Geographic Regions Covered

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

View Report

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

View Report

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

View Report

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

View Report

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

View Report

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

View Report

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

View Report

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

View Report

Colorectal Cancer Drugs Market 2025

Colorectal Cancer Drugs Market 2025

Market Insights

Related Reports

Colorectal Cancer Drugs Market Definition

Colorectal Cancer Drugs Market Size

Colorectal Cancer Drugs Market Drivers

Colorectal Cancer Drugs Market Restraints

Colorectal Cancer Drugs Market Trends

Opportunities And Recommendations In The colorectal cancer drugs Market

Colorectal Cancer Drugs Market Segmentation

Colorectal Cancer Drugs Market Competitive Landscape

Major Competitors are:

Other Competitors Include:

Table Of Contents

List Of Tables

List Of Figures

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

Frequently Asked Questions